Oxford GlycoSciences CEO Kranda to Step Down | GenomeWeb

NEW YORK, March 7 - Oxford GlycoSciences on Thursday said that CEO Michael Kranda will step down by the end of this year.

The company said Kranda, who has been at OGS for six years, cited "personal family reasons" for his decision to leave. Chairman G. Kirk Raab said the company has begun looking for a replacement.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.